中文 | EN
PRODUCTS & SERVICES
Home > PRODUCTS & SERVICES > Fertility Reproduction
Non-invasive Prenatal Testing Version 1.0
  • Introduction
  • Applicable
Introduction

Non-invasive Prenatal Testing Version 1.0 (NIPT v1.0), is an upgraded product of NIPT. By upgrading and optimizing the analytical workflow of NIPT, NIPT v1.0 increases the screening number of diseases to 18.

Based on an innovative NIPT-SCCD analytical workflow, NIPT v1.0 adopts a two-channel data analytical model and a three-dimensional filtering system, which can detect 18 fetal chromosomal diseases simultaneously, including trisomy 21, trisomy 18, trisomy 13, and 11 microdeletion and microduplication syndromes with relatively high incidence.

Applicable
  • NIPT v1.0 is appropriate for pregnant women with fully informed the technical characteristics of prenatal screening and diagnostic methods, and voluntarily choose NIPT v1.0, particularly those with a singleton or twin pregnancy over 12+0 weeks of gestation;
  • Pregnant women who are at moderate risk of common chromosome aneuploidy through Down's serological screening and ultrasonic imaging examination;
  • Pregnant women with contraindications to invasive prenatal diagnosis (such as threatened abortion, fever, bleeding tendency, and unhealed infection, etc.);
  • Pregnant women who missed the optimal time for serological screening or prenatal diagnosis.